Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias

Francesca Vinchi, Richard Sparla, Sara T. Passos, Richa Sharma, S. Zebulon Vance, Hala S. Zreid, Hesham Juaidi, Deepa Manwani, Karina Yazdanbakhsh, Vijay Nandi, André M.N. Silva, Anand R. Agarvas, Eitan Fibach, John D. Belcher, Gregory M. Vercellotti, Husam Ghoti, Martina U. Muckenthaler

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Increasing evidence suggests that free haem and iron exert vasculo-toxic and pro-inflammatory effects by activating endothelial and immune cells. In the present retrospective study, we compared serum samples from transfusion-dependent patients with β-thalassaemia major and intermedia, hereditary spherocytosis and sickle cell disease (SCD). Haemolysis, transfusions and ineffective erythropoiesis contribute to haem and iron overload in haemolytic patients. In all cohorts we observed increased systemic haem and iron levels associated with scavenger depletion and toxic ‘free’ species formation. Endothelial dysfunction, oxidative stress and inflammation markers were significantly increased compared to healthy donors. In multivariable logistic regression analysis, oxidative stress markers remained significantly associated with both haem- and iron-related parameters, while soluble vascular cell adhesion molecule 1 (sVCAM-1), soluble endothelial selectin (sE-selectin) and tumour necrosis factor α (TNFα) showed the strongest association with haem-related parameters and soluble intercellular adhesion molecule 1 (sICAM-1), sVCAM-1, interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) with iron-related parameters. While hereditary spherocytosis was associated with the highest IL-6 and TNFα levels, β-thalassaemia major showed limited inflammation compared to SCD. The sVCAM1 increase was significantly lower in patients with SCD receiving exchange compared to simple transfusions. The present results support the involvement of free haem/iron species in the pathogenesis of vascular dysfunction and sterile inflammation in haemolytic diseases, irrespective of the underlying haemolytic mechanism, and highlight the potential therapeutic benefit of iron/haem scavenging therapies in these conditions.

Original languageEnglish (US)
Pages (from-to)637-658
Number of pages22
JournalBritish journal of haematology
Issue number3
Early online dateMar 15 2021
StatePublished - May 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.


  • haemoglobinopathies
  • haemolysis
  • haemopexin
  • heme
  • iron
  • transfusion


Dive into the research topics of 'Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias'. Together they form a unique fingerprint.

Cite this